Cargando…

Combination vinblastine, prednisolone and toceranib phosphate for treatment of grade II and III mast cell tumours in dogs

This retrospective study evaluates the progression‐free interval and survival outcomes of 40 canine (Canis familiaris) patients with Patnaik grade II and III mast cell tumours treated with combination vinblastine, prednisolone and toceranib phosphate from 2011 to 2015. Patients were subdivided into...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olsen, Jaime A., Thomson, Maurine, O'Connell, Kathleen, Wyatt, Ken
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090407/ https://www.ncbi.nlm.nih.gov/pubmed/29797551 http://dx.doi.org/10.1002/vms3.106

Ejemplares similares

Tolerability of a rapid‐escalation vinblastine‐prednisolone protocol in dogs with mast cell tumours
por: Serra Varela, Juan Carlos, et al.
Publicado: (2016)

c‐Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine
por: Weishaar, K.M., et al.
Publicado: (2017)

Pulse‐Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs
por: Burton, J.H., et al.
Publicado: (2015)

A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma
por: Rippy, Sarah B., et al.
Publicado: (2016)

Effects of Toceranib Phosphate on Systolic Blood Pressure and Proteinuria in Dogs
por: Tjostheim, S.S., et al.
Publicado: (2016)

Erratum to: A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma
por: Rippy, Sarah B., et al.
Publicado: (2016)

Effects of toceranib phosphate (Palladia) monotherapy on multidrug resistant lymphoma in dogs
por: YAMAZAKI, Hiroki, et al.
Publicado: (2017)

Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumor
por: Halsey, Charles HC, et al.
Publicado: (2014)

Effects of Toceranib Phosphate on the Hypothalamic‐Pituitary‐Thyroid Axis in Tumor‐Bearing Dogs
por: Hume, K.R., et al.
Publicado: (2017)

Assessment of postoperative adjuvant treatment using toceranib phosphate against adenocarcinoma in dogs
por: Yamazaki, Hiroki, et al.
Publicado: (2020)

Toceranib phosphate-associated nephrotic syndrome in a dog: a case report
por: Remerowski, Shannon M., et al.
Publicado: (2021)

Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of gastrointestinal stromal tumors of dogs
por: Berger, Erika P., et al.
Publicado: (2018)

Toceranib phosphate and firocoxib-mediated partial response in a dog with advanced intranasal sarcoma
por: OSADA, Hironari, et al.
Publicado: (2023)

Long-term survival in a dog with primary hepatic neuroendocrine tumor treated with toceranib phosphate
por: ICHIMATA, Masanao, et al.
Publicado: (2021)

A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease.
por: McElwain, T. J., et al.
Publicado: (1977)

Toceranib phosphate (Palladia) for the treatment of canine exocrine pancreatic adenocarcinoma
por: Musser, Margaret L., et al.
Publicado: (2021)

Treatment of multiple synchronous canine mast cell tumours using intratumoural tigilanol tiglate
por: Brown, Graham K., et al.
Publicado: (2022)

Evaluation of toceranib for treatment of apocrine gland anal sac adenocarcinoma in dogs
por: Heaton, Caitlin M., et al.
Publicado: (2020)

Evaluation of the adverse event profile and pharmacodynamics of toceranib phosphate administered to dogs with solid tumors at doses below the maximum tolerated dose
por: Bernabe, Luis Feo, et al.
Publicado: (2013)

Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of inoperable, metastatic, or recurrent canine pheochromocytomas: 5 dogs (2014–2017)
por: Musser, Margaret L., et al.
Publicado: (2018)

Toceranib phosphate (Palladia) reverses type 1 diabetes by preserving islet function in mice
por: KISHI, Kazuhisa, et al.
Publicado: (2023)

Long-term survival in a cat with pancreatic adenocarcinoma treated with surgical resection and toceranib phosphate
por: Todd, Johanna E, et al.
Publicado: (2020)

Palmar–plantar erythrodysesthesia syndrome resulting from toceranib phosphate in a dog with apocrine gland anal sac adenocarcinoma: a case report
por: Kim, Eunjoo, et al.
Publicado: (2023)

Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisone
por: Webster, Joshua D, et al.
Publicado: (2008)

Plasma cytokeratin‐18 concentrations as noninvasive biomarker of early gastrointestinal toxicosis in dogs receiving toceranib
por: Kovac, Rachel L., et al.
Publicado: (2018)

Case report: Toceranib as adjuvant chemotherapy in a dog with incompletely resected combined hepatocellular-cholangiocarcinoma
por: Kim, Sang-Won, et al.
Publicado: (2023)

A Multi-Institutional Retrospective Analysis of Toceranib Phosphate for Presumed or Confirmed Canine Aortic Body Chemodectomas
por: Coto, Giovanna M., et al.
Publicado: (2021)

Toceranib phosphate in the management of canine insulinoma: A retrospective multicentre study of 30 cases (2009–2019)
por: Sheppard‐Olivares, Sabina, et al.
Publicado: (2022)

Prevalence and risk factors for mast cell tumours in dogs in England
por: Shoop, Stephanie JW, et al.
Publicado: (2015)

Characterization of receptor tyrosine kinase activation and biological activity of toceranib phosphate in canine urothelial carcinoma cell lines
por: Korec, Daniela I., et al.
Publicado: (2021)

Prednisolone prescribing practices for dogs in Australia
por: Purcell, Bonnie, et al.
Publicado: (2023)

Transcriptome of Two Canine Prostate Cancer Cells Treated With Toceranib Phosphate Reveals Distinct Antitumor Profiles Associated With the PDGFR Pathway
por: Kobayashi, Priscila E., et al.
Publicado: (2020)

Feline restrictive orbital myofibroblastic sarcoma treated with toceranib phosphate (Palladia) as adjuvant chemotherapy: A case study of one cat
por: Komatsu, Hiroyuki, et al.
Publicado: (2023)

Case report: Adjuvant therapy with toceranib for an incompletely resected renal cell carcinoma with suspected pulmonary metastasis in a dog
por: Lee, Da-Eun, et al.
Publicado: (2023)

Presumptive primary intrathoracic mast cell tumours in two dogs
por: Cartagena-Albertus, Juan Carlos, et al.
Publicado: (2019)

LGG-09. SENOLYTIC AGENT NAVITOCLAX TARGETS VINBLASTINE- AND MAPK INHIBITORS-INDUCED SENESCENT TUMOUR CELLS IN PAEDIATRIC LOW GRADE GLIOMAS
por: Guiho, Romain, et al.
Publicado: (2021)

Tolerability and Effects of 2-Aminoethyl Dihydrogen Phosphate in Dogs With Mast Cell Tumors
por: Januário, Eric Vieira, et al.
Publicado: (2022)

Vinblastine in the treatment of Hodgkin's disease.
por: Jelliffe, A. M.
Publicado: (1969)

Inhibition of interferon secretion by vinblastine
por: Havell, EA, et al.
Publicado: (1975)

Vinblastine-induced Acral Hyperpigmentation
por: Chakraborti, Annesha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ci5e6a86nd14albpml3e3f61e3